Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR12D2 Inhibitors

Chemical inhibitors of OR12D2 function by directly binding to the protein, thus preventing its activation by natural odorant ligands. Methyl anthranilate can inhibit OR12D2 by occupying the ligand-binding site, which is typically reserved for the protein's natural activators. This occupation prevents the protein from undergoing the conformational changes required for signal transduction. Similarly, α-Terpineol acts on OR12D2 by binding to an allosteric site, distinct from the natural ligand-binding domain, inducing a conformational shift that reduces the protein's ability to bind its natural ligands. Eugenol and Citronellal follow a comparable mechanism, where they competitively bind to OR12D2's active site, effectively blocking the interaction with odorant molecules that would normally trigger a response. Limonene and Menthol also inhibit OR12D2 by binding to the ligand-binding domain, but they potentially induce an inactive receptor conformation, which prevents the receptor from activating even when natural ligands are present. Further, Geraniol, Citral, and Benzaldehyde all share a similar inhibitory action on OR12D2 by binding to the receptor's active site, precluding the association with natural activating ligands, and consequently inhibiting the receptor's function. Carvone's inhibition of OR12D2 is characterized by its competitive binding to the active site, which obstructs the natural odorants' access to the receptor and prevents activation. Isoeugenol and Thymol inhibit OR12D2 through a mechanism where they bind to the active site and block the conformational changes necessary for signal transduction. These chemicals ensure that OR12D2 remains in a state that is not conducive to activation, effectively silencing the receptor's potential response to stimuli. Each chemical's interaction with OR12D2 is specific to either the active site or an allosteric site, which ensures that the protein's normal activity is hindered, maintaining the receptor in an inhibited state.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Eugenol

97-53-0sc-203043
sc-203043A
sc-203043B
1 g
100 g
500 g
$31.00
$61.00
$214.00
2
(1)

Eugenol can inhibit OR12D2 by competitively binding to the receptor's active site, where the natural odorant molecules would typically bind, thus inhibiting activation of the receptor.

(±)-Citronellal

106-23-0sc-234400
100 ml
$51.00
(0)

This chemical can inhibit OR12D2 by forming a reversible complex with the receptor, altering its conformation and thereby hindering its function.

D-Limonene

5989-27-5sc-205283
sc-205283A
100 ml
500 ml
$82.00
$126.00
3
(1)

Limonene can inhibit OR12D2 by binding to the ligand-binding domain, which may induce an inactive receptor conformation, preventing receptor activation.

(±)-Menthol

89-78-1sc-250299
sc-250299A
100 g
250 g
$38.00
$67.00
(0)

Menthol can inhibit OR12D2 by binding to the receptor site and causing a change in the protein's structure that hinders the receptor's ability to be activated by its natural ligands.

Geraniol

106-24-1sc-235242
sc-235242A
25 g
100 g
$44.00
$117.00
(0)

Geraniol can inhibit OR12D2 by binding to the receptor's active site, which prevents the binding of the endogenous activating ligands, thereby inhibiting the receptor's function.

Citral

5392-40-5sc-252620
1 kg
$212.00
(1)

Citral can inhibit OR12D2 by binding to the receptor's active site and blocking activation through competitive inhibition with natural ligands.

(+)-Carvone

2244-16-8sc-239480
sc-239480A
5 ml
25 ml
$32.00
$82.00
2
(1)

Carvone can inhibit OR12D2 by binding to the receptor's active site, competitively inhibiting the binding of natural odorants and thus receptor activation.

Isoeugenol

97-54-1sc-250186
sc-250186A
5 g
100 g
$62.00
$52.00
(0)

Isoeugenol can inhibit OR12D2 by binding to the active site and preventing the conformational changes necessary for the receptor to transmit a signal.

Thymol

89-83-8sc-215984
sc-215984A
100 g
500 g
$97.00
$193.00
3
(0)

Thymol can inhibit OR12D2 by binding to the receptor's ligand-binding domain, resulting in inhibition of the receptor's normal function through competitive inhibition.